You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 2, Aug 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Streptomycin-Induced Hemolytic Anemia

RALPH NACHMAN, M.D.; JAMSHID JAVID, M.D.; STEPHEN KRAUSS, M.D.

Arch Intern Med. 1962;110(2):187-190.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Two major mechanisms are generally implicated in drug-induced hemolytic anemia. (1) A genetically determined deficiency of erythrocyte glucose-6-phosphate dehydrogenase renders the red cell susceptible to the hemolytic action of certain ordinarily harmless drugs. This was first described in primaquine-induced anemia1 and subsequently in anemia due to numerous other drugs.2 (2) A drug-erythrocyte complex stimulates the production of antibodies which are capable of destroying the patient's erythrocytes in the presence of the drug. Stibophen (Fuadin)3 was the first drug reported to cause hemolysis by this haptenlike action. Other drugs similarly implicated include quindine,4 methylethylhydantoin ( Mesantoin),5 phenacetin,6 and aminosalicylic acid.6

Other agents such as sodium taurocholate and saponin can cause hemolysis7 apparently by a direct lytic action on the erythrocytes; this direct mechanism, however, is rarely of clinical significance.

The following is the first reported case of streptomycin-induced hemolytic anemia, the mechanism of . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

Medical Division and the Department of Hematology, Laboratory Division, Montefiore Hospital.; Postdoctoral Research Fellow, Jane Coffin Childs Memorial Fund for Medical Research (Dr. Javid).


Footnotes

Submitted for publication Dec. 6, 1961.

This study was supported by Grant No. H5415 of the National Heart Institute, National Institutes of Health, U.S. Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.